Tevogen Bio Holdings Inc.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| – | – | – | – | – | |
| – | – | – | +6.7% | – | |
| – | – | – | – | – | |
| – | +95.4% | -23.7% | +604.7% | -64.2% | |
| – | -42.7% | +138.6% | +890.8% | -33.3% | |
| – | -79.4% | +788.1% | +528.0% | -50.8% | |
| – | – | – | – | – | |
| – | -100.0% | – | -28.1% | +6.3% | |
| – | – | -1,471.9% | – | – | |
| – | – | – | – | – | |
| – | – | -1,471.9% | – | – | |
| – | – | -1,369.5% | – | – |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.